Estimated Control Closed Transaction verified Consumer Health

Boehringer Ingelheim Consumer Healthcare business acquired by Sanofi

Sanofi acquired Boehringer Ingelheim Consumer Healthcare business, a Global / Germany consumer healthcare / otc pharmaceuticals brand, on Jan 4, 2017.

Transaction summary

Target
Boehringer Ingelheim Consumer Healthcare business
Acquirer
Sanofi
Announced
2016-06-27
Completed
2017-01-04
Geography
Global / Germany
Tags
Consumer Health
1 more tag
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-10-31

Value and multiples

100% enterprise value

USD 7.3B

100% enterprise value | USD

Basis: Estimated

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

4.4x

Period not stated

Basis: FundComb estimate

EV / EBITDA

16.1x

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • Sanofi took over Boehringer Ingelheim’s consumer healthcare business in an asset swap completed in early 2017; PMLiVE reported the whole swap at EUR 21.8bn. FundComb’s comps spreadsheet values the consumer healthcare business at about USD 7.3bn and gives 4.4x revenue and 16.1x EBITDA. These are FundComb estimates, not confirmed by a public source; the revenue, EBITDA and period behind the multiples are not stated.

Other reviewed estimates

Earlier estimates and their sources.

EV/sales multiple of 4.4x and EV/EBITDA multiple of 16.1x come from the pasted VMS spreadsheet; no public web evidence supplied confirms these multiples.
EV / revenue 4.4x | EV / EBITDA 16.1x

Source summary

Sanofi and Boehringer Ingelheim complete €21.8bn asset swap - PMLiVE

Estimated
Open via Google News

Continue your research

Explore more comps →